We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLARI market cap is 195.97M. The company's latest EPS is EUR -0.9839 and P/E is -1.86.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.62B | 3.88B | 4.33B | 4.6B | 5.08B |
| Operating Income | 369.88M | 312.45M | 344.84M | 293.53M | 225.68M |
| Net Income | 114.68M | 39.4M | 91.12M | 22.06M | -105.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 10.94B | 13.2B | 14.31B | 14.57B | 15.18B |
| Total Liabilities | 8.37B | 9.87B | 10.54B | 10.71B | 11.24B |
| Total Equity | 2.57B | 3.32B | 3.76B | 3.87B | 3.94B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 765.71M | 794.93M | 839.97M | 861.7M | 793.17M |
| Investing | -636.25M | -1.1B | -825.28M | -770.26M | -669.52M |
| Financing | -334.86M | 1.11B | 31.38M | -550.13M | -193.61M |
| Market Cap | 195.97M |
| Price to Earnings Ratio | -1.86 |
| Price to Sales Ratio | 0.04 |
| Price to Cash Ratio | 0.29 |
| Price to Book Ratio | 0.05 |
| Dividend Yield | - |
| Shares Outstanding | 106.97M |
| Average Volume (1 week) | 1.6M |
| Average Volume (1 Month) | 1.41M |
| 52 Week Change | -71.38% |
| 52 Week High | 7.25 |
| 52 Week Low | 1.321 |
| Spread (Intraday) | 0.03 (1.62%) |
| Company Name | Clariane SE |
| Address |
21-25, rue balzac paris, paris 75008 |
| Website | https://www.clariane.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
